A 50-year-old nonsmoker with paroxysmal atrial fibrillation was referred to our hospital for pulmonary vein isolation (PVI). He had a known 1-vessel coronary artery disease. Because of stable angina, a drug-eluting stent had been implanted into the midportion of the left anterior descending artery in 2010. Otherwise he was healthy. His medical treatment included warfarin, sotalol, an angiotensin-converting enzyme-inhibitor and a statin. Cryoballoon-PVI (Arctic Front Advance 28 mm; Medtronic) was scheduled under general anesthesia (international normalized ratio, 2-9; minimal activated clotting time, 300 s). After transseptal access, the left PV were targeted first, followed by the right inferior PV and right superior PV, respectively. PVI of all PVs could be visualized in real-time and gained within 40 s. Two freezethaw cycles were used for each PV, except for the left superior PV, which had to be treated 3×, because of an initially ineffective freeze (Table I in the Data Supplement ). The procedure had been uneventful, until a sudden blood pressure drop occurred (70/40 mm Hg), immediately after the second right superior PV-freeze. Cardiac tamponade was excluded. Twelve-lead ECG revealed global ST-depression and progressive ST-elevation in aVR, consistent with coronary main stem occlusion ( Figure 1 ). Pulseless electric activity developed rapidly, necessitating cardiopulmonary resuscitation. Coronary angiography showed a severe spasm of the left coronary main stem, without evidence for air-or thromboembolism (Figure 2A ), which could be completely reverted by balloon dilatation and intracoronary nitroglycerine administration ( Figure 2B ). The right coronary artery showed a less severe spasm, which was treated by nitroglycerine alone (Figure 3A and 3B). Immediately after coronary reperfusion, ventricular fibrillation occurred, affording several direct current shocks. Because of severe global myocardial stunning, without effective myocardial contractions, an extracorporeal cardiac life support system (veno-arterial extracorporeal cardiac life support system) had to be implanted. Myocardial stunning reverted completely during the following 5 days, and the patient could be weaned from the extracorporeal cardiac life support system. He survived without any major focal neurologic deficit, but impairment of short-term memory was apparent during follow-up. Predischarge echocardiography showed normal biventricular function without wall motion abnormalities. About the used cryoballoon device, the manufacturer excluded a technical malfunction.
Case Report
A 50-year-old nonsmoker with paroxysmal atrial fibrillation was referred to our hospital for pulmonary vein isolation (PVI). He had a known 1-vessel coronary artery disease. Because of stable angina, a drug-eluting stent had been implanted into the midportion of the left anterior descending artery in 2010. Otherwise he was healthy. His medical treatment included warfarin, sotalol, an angiotensin-converting enzyme-inhibitor and a statin. Cryoballoon-PVI (Arctic Front Advance 28 mm; Medtronic) was scheduled under general anesthesia (international normalized ratio, 2-9; minimal activated clotting time, 300 s). After transseptal access, the left PV were targeted first, followed by the right inferior PV and right superior PV, respectively. PVI of all PVs could be visualized in real-time and gained within 40 s. Two freezethaw cycles were used for each PV, except for the left superior PV, which had to be treated 3×, because of an initially ineffective freeze (Table I in the Data Supplement ). The procedure had been uneventful, until a sudden blood pressure drop occurred (70/40 mm Hg), immediately after the second right superior PV-freeze. Cardiac tamponade was excluded. Twelve-lead ECG revealed global ST-depression and progressive ST-elevation in aVR, consistent with coronary main stem occlusion (Figure 1 ). Pulseless electric activity developed rapidly, necessitating cardiopulmonary resuscitation. Coronary angiography showed a severe spasm of the left coronary main stem, without evidence for air-or thromboembolism ( Figure 2A ), which could be completely reverted by balloon dilatation and intracoronary nitroglycerine administration ( Figure 2B ). The right coronary artery showed a less severe spasm, which was treated by nitroglycerine alone ( Figure 3A and 3B). Immediately after coronary reperfusion, ventricular fibrillation occurred, affording several direct current shocks. Because of severe global myocardial stunning, without effective myocardial contractions, an extracorporeal cardiac life support system (veno-arterial extracorporeal cardiac life support system) had to be implanted. Myocardial stunning reverted completely during the following 5 days, and the patient could be weaned from the extracorporeal cardiac life support system. He survived without any major focal neurologic deficit, but impairment of short-term memory was apparent during follow-up. Predischarge echocardiography showed normal biventricular function without wall motion abnormalities. About the used cryoballoon device, the manufacturer excluded a technical malfunction.
Discussion
In this case report, to date, we describe an unreported serious complication of a near-fatal coronary artery main stem spasm during cryoballoon-PVI. We suspect cryoenergy-induced blood cooling, as the most likely trigger, rather than a direct ablation effect, given the distance between the pulmonary veins and the left main stem ( Figure I in the Data Supplement). Further evidence for this theory is provided in Figure 1 , which retrospectively showed progressive development of T wave inversion and ST depression in the 12-lead ECG, already starting after the first cryoenergy application. These changes were not noticed earlier because the procedure was performed using only a limited number of real-time monitored ECG leads (I, III, aVF, V1, V6). Furthermore, the Manufacturer and User Facility Device Experience-database of the US Food and Drug Administration (FDA MAUDE-database), lists 4 additional adverse events related to ST-segment changes with hemodynamic deterioration during cryoballoon-PVI. 1 Noteworthy, only 2 of these 4 patients survived. Despite scarce details, a coronary vasospasm (left anterior descending and right coronary artery, respectively) occurred in ≥2 of these cases. Therefore, we suspect cold-induced coronary vasospasm as the unifying mechanism in susceptible patients, analogous to the formerly used cold pressure test to induce coronary vasospasm.
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December 2014 vasospasm. In addition, the 12-lead ECG should be continuously monitored throughout the procedure with special attention to ischemic changes. This case report also stresses the need for an onsite surgical support to prevent fatality in such cases. Additional studies will be needed to assess the incidence of this potentially fatal complication and to guide proper patient selection for cryoballoon PVI.
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None. Progressive ECG changes during cryoballoon-pulmonary vein isolation (PVI). ECG tracings during the procedure are shown in chronological order. Left, The resting ECG at the beginning of the procedure. The following panels depict progressive ECG changes after ablation of the respective PVs (minor changes are marked with an arrow). Right, The ECG directly before cardiac arrest.CPR indicates cardiopulmonary resuscitation; LIPV, left inferior pulmonary vein; LSPV, left superior pulmonary vein; RIPV, right inferior pulmonary vein; and RSPV, right superior pulmonary vein.
